On the other hand, loss of function point mutations of the PPARγ gene and polymorphisms in PPARγ genes were encountered in 8% of colorectal carcinoma patients, but some studies on PPARγ expression in colorectal samples did not find any relation of PPARγ immunoreactivity and tumor parameters [36, 37]. The gene discussed is PPARG; the disease is colorectal carcinoma.